Amanote Research
Register
Sign In
Desmopressin and Bleeding Time in Patients With Cirrhosis.
BMJ
doi 10.1136/bmj.291.6506.1377
Full Text
Open PDF
Abstract
Available in
full text
Date
November 16, 1985
Authors
A K Burroughs
K Matthews
M Qadiri
N Thomas
P Kernoff
E Tuddenham
N McIntyre
Publisher
BMJ
Related search
Medical Management of Variceal Bleeding in Patients With Cirrhosis
Canadian Journal of Gastroenterology
The Risk of Bleeding After Invasive Procedures in Patients With Cirrhosis With Severe Coagulopathy
Hepatology
Medicine
Hepatology
Effect of Desmopressin on the Amount of Bleeding and Transfusion Requirements in Patients Undergoing Heart Transplant Surgery
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Can Hellicobacter Pylori Infection Increase the Risk of Variceal Bleeding in Patients With Liver Cirrhosis?
Journal of Liver Research, Disorders & Therapy
Surgical Methods of Bleeding Prevention From Esophageal Varices in Treatment for Patients With Liver Cirrhosis
Grekov's Bulletin of Surgery
Von Willebrand Factor and Factor VIII Levels After Desmopressin Are Associated With Bleeding Phenotype in Type 1 VWD
Blood advances
Hematology
Changes in Cholesterol Metabolism During Acute Upper Gastrointestinal Bleeding: Liver Cirrhosis and Non Cirrhosis Compared
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Biochemistry
Medicine
Genetics
Molecular Biology
Systolic and Diastolic Dysfunction in Patients With Cirrhosis
Journal of Evolution of Medical and Dental Sciences
Neurohumoral Systems in Patients With Cirrhosis
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine